semaglutide supplement What is Ozempic® Pill? Oral semaglutide shows promising results

Retatrutide (LY3437943) is an investigational compound and is not approved by the FDA, EMA, or any comparable regulator for the treatment, cure, or prevention of polycystic ovary syndrome, insulin resistance, obesity, type 2 diabetes, or any other disease

[DOI] [PMC free article] [PubMed] [Google Scholar] 105.Li X., Ren Y., Chang K., Wu W., Griffiths H.R., Lu S., Gao D

But when metabolic health is off-track, it can lead to problems like high blood sugar levels and excess weight

Even at lower doses, the results were impressivepeople taking 8 mg lost around 17% of their body weight in 24 weeks

H.SlomaE.et al (2018)

The goal is to stabilize